---
title: Innovation to Adopt (I2Adopt)
permalink: /funding/innovation-to-adopt/
description: ""
third_nav_title: Funding
---
Innovation to Adopt (I2Adopt)
-----------------------------

#### Funding which supports commercially viable innovation for implementation, adoption

<img src="/images/Funding/logos_i2adopt.jpg" style="width:300px" align="right">

##### Aim

Funding to support development of a clinically significant and commercially viable innovation to accelerate commercialization and&nbsp;**eventual implementation and adoption**&nbsp;of the innovation to&nbsp;**impact and benefit**&nbsp;healthcare delivery and patient care

##### Eligibility

The Principal Investigator must hold a primary appointment in and be under the employment of a public healthcare institution in Singapore.

*   Considerations for project gearing toward clinical adoption:

*   *   Commercial position: Interest to trial for eventual implementation and adoption cross cluster.
    *   Ideally with two or more clusters indicating interest to implement &amp; adoption post pilot (in a letter of support/interest)
    *   Approved/Registered or close to regulatory approval or registration; ethics submission or approval (as applicable)
    *   Industry partnerâ€™s commitment to pilot and implement

##### Theme (Intervention):

Enabling technologies that improve clinical outcome, including preventive intervention, therapeutic interventions, etc.

##### Funding criteria

Grant applications that emphasise on the following aspects of the project are considered for funding:

*   Well defined unmet healthcare need
*   Clear deployment and product development strategy/roadmap
*   Potential to result in reduced healthcare costs, improved clinical outcome and eventual adoption by the healthcare system.
*   Proven scientific merit with proof-of-concept data in in vitro and/or in vivo research/laboratory models
*   Strong intellectual property position will have an advantage

##### Funding Quantum

Up to $1Mil^

&nbsp;_^Quantum reviewed on a Project by Project basis_

##### Funding Duration

12 months, Up to 18 months

##### Grant call opens

Grant call is open, please note submission deadline

Submission through designated Healthcare Cluster Office

<table style="max-width: 100%; background-color: transparent; border-collapse: collapse; border-spacing: 0px; padding: 0px; margin: 10px 0px; width: 855.125px; border-width: 1px; border-color: rgb(222, 222, 222);" cellpadding="10" border="1"><tbody><tr><td><strong style="font-weight: bold;">Healthcare Cluster</strong></td><td><strong style="font-weight: bold;">Designated Research/Innovation Office<br></strong></td></tr><tr><td>National Healthcare Group (NHG)</td><td>NHG Group Research</td></tr><tr><td>National University Health System (NUHS)</td><td>NUHS Research Office</td></tr><tr><td>Singapore Health Services (SingHealth)</td><td>SingHealth Office of Intellectual Property (SHIP)</td></tr></tbody></table>

##### Anticipated Time Line

<table style="max-width: 100%; background-color: transparent; border-collapse: collapse; border-spacing: 0px; padding: 0px; margin: 10px 0px; width: 855.125px; border-width: 1px; border-color: rgb(222, 222, 222);" cellpadding="10" border="1"><tbody><tr><td>&nbsp;</td><td><strong style="font-weight: bold;">Remarks<br></strong></td><td><strong style="font-weight: bold;">Estimated dates<br></strong></td></tr><tr><td>1</td><td>Grant Call Closes</td><td>4 Sept 2023</td></tr><tr><td>2</td><td>Invite to full proposal</td><td>End Oct- Early Nov 2023</td></tr><tr><td>3</td><td>Evaluation</td><td>Jan 2024</td></tr><tr><td>4</td><td>Funding Decision</td><td>End Jan-Mid Feb 2024</td></tr></tbody></table>

##### Grant Process

![](/images/Funding/i2a_clinicalinnovation.png)

*   All grant applications are evaluated based on the criteria detailed below.
*   LOI template can be downloaded&nbsp;[here](https://nhic.sg/web/index.php/downloads)
*   Only shortlisted applicants will be invited to submit full proposal and pitch to the Evaluation Panel
*   For further queries on this grant, please contact NHIC at&nbsp;[grant@nhic.cris.sg](mailto:grant@nhic.cris.sg)

##### NHIC I2Adopt Evaluation Criteria Considerations

<table style="max-width: 100%; background-color: transparent; border-collapse: collapse; border-spacing: 0px; padding: 0px; margin: 10px 0px; width: 855.125px; border-width: 1px; border-color: rgb(222, 222, 222);" cellpadding="10" border="1"><tbody><tr><td><strong style="font-weight: bold;">Category</strong></td><td><strong style="font-weight: bold;">Considerations</strong></td></tr><tr><td>Background &amp; data</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">What is the level of maturity? (evidence to demonstrate the safety and efficacy of the solution)</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is the clinical gap and clinical workflow clear?</li></ol></td></tr><tr><td>Uniqueness of technology</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">How is the product /solution better than current options in the market?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">What is the market size, competitive landscape, route to market?</li></ol></td></tr><tr><td>Implementation plan &amp; deliverables</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Readiness of deployment, has it been deployed or implemented in healthcare system?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there intention of support to co-develop and/or trial and/or implement cross-cluster from PHIs?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Does the proposal include coherent, logical product deployment roadmap? Are clear logical methodologies to overcome potential deployment barriers outlined?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Does data from the technology support and de-risk implementation challenges?</li></ol></td></tr><tr><td>Business Considerations</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there management, stakeholder buy-in and support for adoption?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there any co-innovation/co-development potential?</li></ol></td></tr><tr><td>Healthcare impact</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is the clinical need elaborated, evidenced clearly?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there clear validated evidence of advantage of the innovation as compared to others? (through cost-savings, increased value, benefits to healthcare)</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there potential for global commercialization?</li></ol></td></tr><tr><td>Team Composition</td><td><ol style="padding: 0px; margin: 5px 0px;"><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is Project Team experienced in innovation, translation to engage stakeholders for implementation?</li><li style="line-height: 20px; padding: 0px; margin: 0.3em 0px 0.3em 2em;">Is there commitment and adequate support from industry partner?</li></ol></td></tr><tr><td>Budget</td><td>Is the budget realistic for the work outlined?</td></tr></tbody></table>

##### Frequently Asked Questions (FAQs)

Please refer to our list of&nbsp;[FAQs for more information](/programmes/faqs/).